Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ·Healthcare·Biotechnology
$164.06
-6.11%
Mkt Cap $30.46B
Analyst Ratings
Buy
28
Hold
8
Sell
0
Price Target (87 analysts)
$347.33
Range $256.00 – $455.00
Implied Upside
+111.7%
Consensus $347.33 vs current $164.06